A Third Pfizer COVID-19 Vaccine Dose Is Likely To Be Required Within A Year

The CEO says annual revaccinations are also possible.
Contributor

A third dose of the originally two-dose Pfizer COVID-19 vaccine may be on the way.

Pfizer has been testing a booster ever since February in order to see if it would add protection from the circulating COVID-19 variants, and the company's CEO now says it may soon be time to roll it out.

Editor's Choice: The CDC & FDA Are Urging A 'Pause' For The Johnson & Johnson COVID-19 Vaccine

In a CVS Health panel, CEO Albert Bourla says the demand for a third dose is likely to come in "somewhere between 6 and 12 months," and then there could be a need for yearly revaccination, much like the flu vaccine.

Moderna, the company responsible for another two-dose vaccine, is also experimenting with a booster in response to variants that were first identified in the U.K. and South Africa, for example.

CEO Stephane Bancel told CNBC that their third booster could become available later in fall or winter 2021.

  • Noah Borden was an Associate Editor for Narcity Media.

This new Canadian coin is like a black loonie but it's worth much more than $1

It has black rhodium plating and high-contrast frostings.

Starbucks' new Snoopy collab is coming to Canada and it's perfect for cozy season

The limited-edition collection has Snoopy cups, plushies and more — but you may need to move fast. ☕️

Ottawa spending $4.7B on new made-in-Canada Via Rail passenger cars

Feds spending $4.7B on new Via Rail passenger cars

Ontario court denies Toronto woman's motion to apply for MAID for mental illness

Toronto woman's motion to apply for MAID for mental illness denied

Canada has a secret desert with powdery dunes and it's like a mini trip to Egypt

It's probably the last thing you'd expect to see in the True North. 🇨🇦